Stefan C Grant Has Joined Duane Morris
12 November 2012
Stefan C Grant has joined Duane Morris as a New York-based partner from Buchanan Ingersoll & Rooney. Grant, who brings extensive experience in the pharmaceutical, biotechnology and biopharmaceutical fields, is also a research and clinical oncologist.
His clients include large and small biotechnology, biopharmaceutical, biomedical and pharmaceutical companies, as well as investment banks and venture capital groups, in pharmaceutical and biotechnology-related patent litigation in the United States and in Europe, including ANDA patent litigation. In addition, he has experience in intellectual property transactions, such as technology transfers, and the due diligence involved in licensing technology both to and from universities and biopharmaceutical companies.
Grant was previously vice president and general counsel of Genta, a NASDAQ-traded biopharmaceutical company that focused on cancer drug treatments, an assistant professor of medicine at Weil Cornell Medical College and an attending physician at Memorial Sloan-Kettering Cancer Center, where he engaged in clinical and laboratory research, including spearheading the development of investigational vaccine therapies, while also managing a large clinical oncology practice.
